• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by TFF Pharmaceuticals Inc.

    11/19/24 4:05:58 PM ET
    $TFFP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $TFFP alert in real time by email
    SC 13G/A 1 d912959dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 3)*

     

     

    TFF Pharmaceuticals, Inc.

    (Name of Issuer)

    Common Stock, $0.001 par value per share

    (Title of Class of Securities)

    87241J104

    (CUSIP Number)

    November 15, 2024

    (Date of Event Which Requires Filing of This Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 87241J104    SCHEDULE 13G    Page 2 of 8 Pages

     

     1   

      NAMES OF REPORTING PERSON

     

     Double Black Diamond Offshore Ltd.

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Cayman Islands

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     124,000

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     124,000

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     124,000

    10  

     CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     3.45%

    12  

     TYPE OF REPORTING PERSON

     

     CO

     

    2


    CUSIP No. 87241J104    SCHEDULE 13G    Page 3 of 8 Pages

     

     1   

      NAMES OF REPORTING PERSON

     

     Carlson Capital, L.P.

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     124,000

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     124,000

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     124,000

    10  

     CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     3.45%

    12  

     TYPE OF REPORTING PERSON

     

     PN, IA

     

    3


    CUSIP No. 87241J104    SCHEDULE 13G    Page 4 of 8 Pages

     

     1   

      NAMES OF REPORTING PERSON

     

     Asgard Investment Corp. II

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     124,000

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     124,000

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     124,000

    10  

     CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     3.45%

    12  

     TYPE OF REPORTING PERSON

     

     CO

     

    4


    CUSIP No. 87241J104    SCHEDULE 13G    Page 5 of 8 Pages

     

     1   

      NAMES OF REPORTING PERSON

     

     Clint D. Carlson

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     124,000

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     124,000

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     124,000

    10  

     CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     3.45%

    12  

     TYPE OF REPORTING PERSON

     

     IN

     

    5


    Explanatory Note

    This Amendment No. 3 (the “Amendment”) amends the initial statement on Schedule 13G filed by the Reporting Persons on November 22, 2022 (as amended prior to the date hereof, the “Original Filing”, as amended by Amendment No. 1 filed by the Reporting Persons on December 31, 2022, as amended by Amendment No. 2 filed by the Reporting Persons on December 31, 2023, and as amended by this Amendment No. 3, the “Statement”). Except as specifically provided herein, this Amendment No. 3 does not modify any of the information previously reported in the Original Filing. Capitalized terms used but not defined have the meaning given them in the Original Filing.

     

    Item 1(a).

    NAME OF ISSUER

    TFF Pharmaceuticals, Inc., a Delaware corporation (the “Issuer”).

     

    6


    Item 4.

    OWNERSHIP

     

      A.

    The Fund:

     

      (a)

    Amount beneficially owned: 124,000 shares of Common Stock (consisting of 124,000 shares of Common Stock issuable upon exercise of 1,300,000 warrants)

     

      (b)

    Percent of class: 3.45%

     

      (c)

    (i)  Sole power to vote or direct the vote: 0

     

      (ii)

    Shared power to vote or direct the vote: 124,000

     

      (iii)

    Sole power to dispose or direct the disposition: 0

     

      (iv)

    Shared power to dispose or direct the disposition: 124,000

     

      B.

    Carlson Capital:

     

      (a)

    Amount beneficially owned: 124,000

     

      (b)

    Percent of class: 3.45%

     

      (c)

    (i)  Sole power to vote or direct the vote: 0

     

      (ii)

    Shared power to vote or direct the vote: 124,000

     

      (iii)

    Sole power to dispose or direct the disposition: 0

     

      (iv)

    Shared power to dispose or direct the disposition: 124,000

     

      C.

    Asgard II:

     

      (a)

    Amount beneficially owned: 124,000

     

      (b)

    Percent of class: 3.45%

     

      (c)

    (i)  Sole power to vote or direct the vote: 0

     

      (ii)

    Shared power to vote or direct the vote: 124,000

     

      (iii)

    Sole power to dispose or direct the disposition: 0

     

      (iv)

    Shared power to dispose or direct the disposition: 124,000

     

      D.

    Mr. Carlson:

     

      (a)

    Amount beneficially owned: 124,000

     

      (b)

    Percent of class: 3.45%

     

      (c)

    (i)  Sole power to vote or direct the vote: 0

     

      (ii)

    Shared power to vote or direct the vote: 124,000

     

      (iii)

    Sole power to dispose or direct the disposition: 0

     

      (iv)

    Shared power to dispose or direct the disposition: 124,000

    The percentages reported in this Schedule 13G are based on 3,466,041 shares of Common Stock outstanding as of August 12, 2024, as of the Form 10-Q filed with the Securities and Exchange Commission on August 14, 2024.

     

    Item 5.

    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☒.

     

    7


    SIGNATURES

    After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    DATED: November 19, 2024

     

    DOUBLE BLACK DIAMOND OFFSHORE LTD.
    By: Carlson Capital, L.P., its investment manager
    By: Asgard Investment Corp. II, its general partner
    By:  

    /s/ Clint D. Carlson

    Name:   Clint D. Carlson
    Title:   President
    CARLSON CAPITAL, L.P.
    By: Asgard Investment Corp. II, its general partner
    By:  

    /s/ Clint D. Carlson

    Name:   Clint D. Carlson
    Title:   President
    ASGARD INVESTMENT CORP. II
    By:  

    /s/ Clint D. Carlson

    Name:   Clint D. Carlson
    Title:   President
    CLINT D. CARLSON

    /s/ Clint D. Carlson

     

    8

    Get the next $TFFP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TFFP

    DatePrice TargetRatingAnalyst
    5/19/2022$22.00Buy
    H.C. Wainwright
    More analyst ratings